Pharming Group N.V. (PHAR)

Pharming Group Income Statement

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	258.36	245.32	205.62	198.87	212.17	189.39
Revenue Growth (YoY)	28.19%	19.30%	3.39%	-6.27%	12.03%	40.15%
Cost of Revenue	29.52	25.21	17.56	21.14	23.54	23.93
Gross Profit	228.84	220.1	188.06	177.73	188.64	165.46
Selling, General & Admin	188.17	179.93	131.82	96.42	75.69	65.92
Research & Development	71.82	68.91	52.53	70.37	38.52	31.79
Other Operating Expenses	-23.12	-23.35	-14.52	-2.62	-1.83	-0.49
Operating Expenses	236.87	225.49	169.83	164.17	112.38	97.22
Operating Income	-8.04	-5.39	18.23	13.56	76.26	68.25
Other Expense / Income	3.93	6.63	3.25	-9.52	32.16	15.94
Pretax Income	-11.96	-12.01	14.99	23.08	44.09	52.3
Income Tax	-1.17	-1.46	1.31	7.08	6.35	11.75
Net Income	-10.79	-10.55	13.67	16	37.75	40.56
Net Income Growth	-	-	-14.52%	-57.62%	-6.93%	62.27%
Shares Outstanding (Basic)	671	659	649	639	638	638
Shares Change	2.24%	1.61%	1.55%	0.12%	-	-
EPS (Basic)	-0.16	-0.16	0.21	0.25	0.58	0.65
EPS (Diluted)	-0.18	-0.16	0.19	0.23	0.55	0.60
EPS Growth	-	-	-17.39%	-58.18%	-8.33%	57.89%
Free Cash Flow	-3.47	-18.74	21.08	27.1	78.97	71.5
Free Cash Flow Per Share	-0.05	-0.28	0.33	0.42	1.24	1.12
Gross Margin	88.57%	89.72%	91.46%	89.37%	88.91%	87.37%
Operating Margin	-3.11%	-2.20%	8.87%	6.82%	35.94%	36.03%
Profit Margin	-4.18%	-4.30%	6.65%	8.04%	17.79%	21.41%
Free Cash Flow Margin	-1.34%	-7.64%	10.25%	13.63%	37.22%	37.75%
Effective Tax Rate	-	-	8.76%	30.69%	14.40%	22.46%
EBITDA	7.58	3.91	28.18	42.69	52.41	58.11
EBITDA Margin	2.93%	1.60%	13.70%	21.47%	24.70%	30.68%
Depreciation & Amortization	19.54	15.93	13.19	19.61	8.31	5.8
EBIT	-11.96	-12.01	14.99	23.08	44.09	52.3
EBIT Margin	-4.63%	-4.90%	7.29%	11.60%	20.78%	27.62%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).